Species Reactivity: Mouse, Human, Rat, Dog, Pig, Cow, Horse
Summary
Specifications
Antibody Isotype
IgG
Species Reactivity
Mouse; Human; Rat; Dog; Pig; Cow; Horse
Immunogen
KLH conjugated synthetic peptide derived from human Cip4: 151-250/601
Conjugate
Unconjugated
Applications
Application Notes
WB: 1:500-2000
General Notes
This product (Catalog No. DPABH-21475) is a rabbit-derived IgG polyclonal antibody raised against human TRIP10, targeting the amino acid region 151–250 of the protein. This antibody exhibits cross-reactivity with TRIP10 from mouse, rat, dog, pig, cow, and horse. It has been affinity purified by Protein A. Enables identical protein binding activity. Predicted to be involved in actin cytoskeleton organization and signal transduction. Located in nucleoplasm. Biomarker of Huntington's disease. DPABH-21475 is suitable for use in Western blot (WB) (1:500–1:2,000) application. DPABH-21475 is supplied as a liquid formulation in 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. For long-term storage, keep at −20 °C. For short-term use, store at 2–8 °C. Avoid repeated freeze–thaw cycles to maintain antibody integrity and performance.
Target
Alternative Names
Cdc42 interacting protein 4; Cdc42 interaction protein 4 long isoform; Cdc42-interacting protein 4; Cip 4; CIP4_HUMAN; DCIP4; hSTP; Protein Felic; Salt tolerant protein; Salt tolerator; STOT; STP; Thyroid hormone receptor interactor 10; Thyroid receptor interacting protein 10; Thyroid receptor-interacting protein 10; TR-interacting protein 10; TRIP 10; TRIP-10; trip10; Truncated Cdc42 interaction protein 4
My Review for Rabbit Anti-Human Cip4 (a.a. 151-250) Polyclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.